Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06689215 · ClinicalTrials.gov registry record
Comparison of Noninvasive vs. Invasive Hemodynamic Measurements
A clinical trial of Heart Failure, Congestive, sponsored by Nihon Kohden.
- Active
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT06689215: Active study of Heart Failure, Congestive, sponsored by Nihon Kohden.
NCT06689215 is a study of Heart Failure, Congestive that is active but no longer recruiting, run by Nihon Kohden. The registered enrollment target is 30 participants, below the 674-participant average among 39 other Heart Failure, Congestive trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06689215, a study of Heart Failure, Congestive, is active but no longer recruiting, sponsored by Nihon Kohden.
- ACTIVE NOT RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparison of a non-invasive method of measuring central venous pressure to the conventional modality of invasive central venous pressure.
Primary Outcome
Evaluate sensitivity and specificity of ezCVP indication based on the case where CVP is in a 'low range' (0 \< CVP \< 10 mmHg) or 'high range' (\>= 10 mmHg)
Conditions Studied
Interventions
- DEVICE Non-invasive central venous pressure
Study Locations (1)
California
- Stanford University Hospital - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-10-21 |
| Est. Completion | 2027-03-30 |
What the registry record for NCT06689215 still lists
NCT06689215 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 674-participant average among 39 other Heart Failure, Congestive trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Heart Failure, Congestive appearing as the primary indexed condition, and to 1 intervention - of which Non-invasive central venous pressure is the first listed.
NCT06689215 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06689215 about?
NCT06689215 is a clinical study titled "Comparison of Noninvasive vs. Invasive Hemodynamic Measurements". Comparison of a non-invasive method of measuring central venous pressure to the conventional modality of invasive central venous pressure.
What is the current status of trial NCT06689215?
This trial is currently active not recruiting. The enrollment target is 30 participants. The study started on 2024-10-21. Estimated completion is 2027-03-30.
What conditions does trial NCT06689215 study?
This clinical trial studies the following conditions: Heart Failure, Congestive.
What interventions are being tested in trial NCT06689215?
The interventions under investigation include: Non-invasive central venous pressure (DEVICE).
Who is sponsoring clinical trial NCT06689215?
This trial is sponsored by Nihon Kohden, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06689215 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure, Congestive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06689215's enrollment target sits among peer trials
30 33rd of 39 higher than 6 of 39 other Heart Failure, Congestive trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure, Congestive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
RECRUITING
-
Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism
RECRUITING
-
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
RECRUITING · Phase 4
-
The ROle of Compression StocKings in Heart Failure Patients
RECRUITING · NA
-
Cardiovascular Health Study (CHS)
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI